deferoxamine has been researched along with vorinostat in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Cohen, SM; Day, JA | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Davidoff, AM; Rankovic, Z; Wang, Y; Wu, Q; Yang, J; Young, B | 1 |
| Bouchecareilh, M; Hutt, DM; Marchal, C; Roth, DM | 1 |
2 review(s) available for deferoxamine and vorinostat
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Recent Advances with KDM4 Inhibitors and Potential Applications.
Topics: Enzyme Inhibitors; Histone Demethylases; Humans; Jumonji Domain-Containing Histone Demethylases; Neoplasms | 2022 |
3 other study(ies) available for deferoxamine and vorinostat
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Investigating the selectivity of metalloenzyme inhibitors.
Topics: Biocatalysis; Carbonic Anhydrase II; Enzyme Assays; Enzyme Inhibitors; Enzymes; Histone Deacetylase 2; Humans; Hydroxamic Acids; Kinetics; Matrix Metalloproteinase 12; Matrix Metalloproteinase 2; Metalloproteins; Molecular Structure; Monophenol Monooxygenase; Peptidyl-Dipeptidase A | 2013 |
Using Histone Deacetylase Inhibitors to Analyze the Relevance of HDACs for Translation.
Topics: Acetylation; Blotting, Western; Cell Line, Tumor; Chromatin; Chromosomal Proteins, Non-Histone; Cyclin D1; Deferoxamine; Eukaryotic Initiation Factor-3; Gene Expression Regulation, Neoplastic; Glycine; Hepatocytes; Histone Acetyltransferases; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Humans; Hydroxamic Acids; Hypoxia-Inducible Factor 1, alpha Subunit; Leupeptins; Protein Biosynthesis; Protein Processing, Post-Translational; RNA, Small Interfering; Vorinostat | 2017 |